A platform to talk about exciting science and ask questions

As a biomedical scientist, my work and work hours look very different from majority of the corporate roles. Some days I complete my 10k steps only within the lab premises and somedays I look at the computer screen for almost the entire day, and then there are days when I return to the lab at 10 pm for ending or starting a time sensitive experiment. Although this might feel like flexible work hours, generally a majority of us, the bench scientists, put at least 50+ hours a wee

For the past couple of years, the conversation surrounding GLP-1 receptor agonists, the “star” class of drugs including Ozempic, Mounjaro, and Wegovy, has focused almost exclusively on the miracle of metabolic transformation. We’ve watched as these medications redefined the treatment of obesity and Type 2 diabetes, offering a lifeline to millions. However, as the medical community progresses in 2026, the honeymoon phase is being met with a hit of reality check. We are no long

Have you ever found yourself staring at a Western blot or a qPCR readout, wondering why the “clean” results you obtained last month have suddenly disappeared? After checking the buffers, calibrating the pipettes, and questioning the antibody, it is easy to conclude that the problem lies in technique. But in cancer research, another possibility deserves equal attention: the biology of the model itself may have changed. Cancer cell lines are not static reagents. In many setting